Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
Xcellerant Ventures is a venture capital firm founded by John Shufeldt, Douglas Sylvester, and Chris Yoo. Established to invest in transformative healthcare technologies, the firm leverages over seven decades of combined experience in medical technologies, law, and entrepreneurship. The firm is headquartered in the United States and focuses on enhancing the quality, efficiency, access, and delivery of healthcare while reducing costs.
Currently, Xcellerant Ventures manages a portfolio of three notable companies and emphasizes early-stage investments, particularly in the healthtech and medtech sectors. The firm has established a reputation for selecting dynamic founders and companies that have cleared regulatory hurdles, demonstrating a clear path to financial growth. Their commitment to addressing real-world healthcare challenges positions them as a key player in the venture capital landscape.
Xcellerant Ventures specializes in early-stage funding for healthtech and medtech companies, focusing on pre-seed, seed, seed-plus, and Series A investment stages. Their investment strategy prioritizes dynamic founders and companies with rapid exit potential. The firm seeks businesses that have successfully navigated regulatory hurdles and exhibit a clear trajectory toward financial growth.
Investment criteria include a strong emphasis on addressing real-world healthcare challenges. Xcellerant Ventures is particularly interested in companies that demonstrate innovative solutions capable of enhancing healthcare delivery and efficiency. This focus on impactful healthcare technologies allows the firm to align its investments with significant market needs.
Xcellerant Ventures has a concentrated portfolio of three notable companies:
These companies exemplify Xcellerant Ventures' commitment to investing in early-stage firms that are poised for significant impact in the healthcare sector.
John Shufeldt: General Partner with extensive experience in medical technologies and law. He has a strong background in entrepreneurship and has led numerous successful ventures.
Douglas Sylvester: General Partner with a focus on healthcare investments. His expertise includes navigating regulatory landscapes and supporting early-stage companies.
Chris Yoo: General Partner who brings a wealth of knowledge in healthtech and medtech sectors. He has a proven track record of identifying promising startups.
Michael Shufeldt: General Partner with a background in law and entrepreneurship, contributing to the firm's strategic direction.
TJ Kline: Team member with experience in healthcare investments and operational support.
James Mago: Team member focused on portfolio management and growth strategies.
Tiffany Youtchoko: Team member with expertise in healthtech market analysis.
Yvette Ferreira: Team member involved in operational support for portfolio companies.
Amanda Best: Team member contributing to investment analysis and due diligence.
Dave Pulver: Team member with a focus on healthcare technology trends.
Anne Mazet: Team member supporting portfolio company growth initiatives.
Haley Ha: Team member involved in market research and investment strategy.
To pitch Xcellerant Ventures, founders should use the Dealum portal to submit their application. The pitch deck should include a clear overview of the business model, market opportunity, and financial projections. Founders are encouraged to provide detailed information about their team and any regulatory milestones achieved. Response times may vary, so patience is advised after submission.
Recently, Xcellerant Ventures has published blog posts discussing the democratization of healthcare through technology and the operational expansion of their portfolio company, Nanodropper, now known as Mu Medical. These posts reflect the firm's ongoing engagement with industry trends and developments.
Additionally, Xcellerant Ventures continues to explore new investment opportunities within the healthtech and medtech sectors, reinforcing their commitment to supporting innovative solutions that address real-world healthcare challenges.
What are Xcellerant Ventures' investment criteria?
Xcellerant Ventures focuses on early-stage healthtech and medtech companies that have cleared regulatory hurdles and demonstrate a clear path to financial growth. They prioritize dynamic founders and companies with rapid exit potential.
How can I apply or pitch to Xcellerant Ventures?
Interested founders can visit the Dealum portal to fill out an application form for funding inquiries. General inquiries can be directed through the contact form on their website.
What makes Xcellerant Ventures different from other firms?
The firm emphasizes investments in companies that address real-world healthcare challenges and have a clear path to financial growth. Their focus on dynamic founders and regulatory compliance sets them apart in the venture capital space.
What is the geographic scope of Xcellerant Ventures?
Xcellerant Ventures primarily invests in companies based in the United States, focusing on innovative healthtech and medtech solutions that can scale effectively.
What is the typical check size for investments?
While specific check sizes are not disclosed, Xcellerant Ventures typically invests in early-stage rounds, which can range from pre-seed to Series A funding.
What level of post-investment involvement can founders expect?
Xcellerant Ventures actively engages with portfolio companies, providing operational support and strategic guidance to help them navigate growth challenges and achieve their objectives.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.